 BURBANK, Calif., June 29, 2021 GLOBE NEWSWIRE -- via NewMediaWire Medolife Rx, Inc. Medolife, a global integrated biopharmaceutical company with RD, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. OTC PINK: QNTA, announced today that it entered into a partnership agreement with Xoles Del Pacifico, S.A. De C.V. Xoles a leading international distributor of pharmaceutical and wellness products, to bring Medolifes consumer brands to the Mexican market. Products to be sold in Mexico through the agreement include Medolifes ImmunapenTM product line, as well as its cannabidiol CBD and non-CBD line of pain reliefmuscle creams. Additionally, Medolife will use its patented polarization technology to enhance existing over-the-counter OTC pharmaceutical-grade white label products, such as male enhancement products and vitamins. 